Capstone Holding Corp Has Four Days to Save Its Nasdaq Listing
CAPS trades at $0.28 with a $1.5 million market cap and a pattern of blown filing deadlines. On July 6, its Nasdaq compliance clock runs out — here's what that actually means.

Capstone Holding Corp (NASDAQ: CAPS) has four days left. On January 7, 2026, Nasdaq sent the company a deficiency letter after its stock fell below the exchange's $1.00 minimum bid price requirement. The compliance deadline is July 6, 2026. As of this week, CAPS trades at $0.28 — a market cap of just $1.5 million, down from a 52-week high near $3.29.
This is a useful case study in what a real going-concern situation looks like from the outside, and how the pieces connect.
The pattern behind the price. Capstone, a tech-enabled building products distributor operating across 38 U.S. states and Canada, has now delayed three consecutive SEC filings — its Q3 2025 10-Q, its 2025 annual report, and its Q1 2026 10-Q. Each delay has been attributed to accounting complexity from two acquisitions completed in 2025: Carolina Stone Holdings and Fraser Canyon Holdings. Integrating an acquisition means purchase price allocations and goodwill impairment testing — real accounting work — but a third consecutive delay is no longer a one-off complication. It's a pattern, and the market is pricing it as one.
The numbers underneath. Trailing twelve-month net margin sits at -46.8%, with return on equity at -94.5%. For fiscal 2025, revenue grew 4.5% year-over-year, but net income fell 728.3% — meaning the company is growing its top line while losing dramatically more money doing it. Debt-to-equity stands at 2.32, and enterprise value ($29.6 million) dwarfs market cap ($1.5 million), which tells you plainly where the company's value actually sits: with creditors, not shareholders, until proven otherwise.
Why the Nasdaq deadline matters more than it sounds. A stock exchange listing isn't just prestige — it's liquidity. Losing Nasdaq status typically means a stock drops to over-the-counter markets, where trading volume thins out, institutional ownership becomes harder to justify, and the bid-ask spread widens. For a company already this thinly capitalized, a delisting would compound its problems rather than just embarrass it. Capstone can regain compliance if its bid price closes at or above $1.00 for a minimum number of consecutive trading days before July 6 — a bar that, at $0.28, would require the stock to nearly quadruple in days, or the company to execute a reverse stock split.
The other side of the ledger. Management has reaffirmed aggressive FY2026 guidance: $72.1 million in revenue (a 54% increase), and a swing to roughly $3.8 million in EBITDA, with a positive EBITDA run-rate targeted for Q2 2026. That's not a small claim for a company this size, and it's the entire bull case in one sentence — if the two acquisitions actually perform once fully integrated, per-share economics could look very different a year from now. The market, currently pricing this at $1.5 million, is saying it doesn't believe that yet.
The lesson for readers: this is what a genuine high-risk micro-cap situation looks like in real time — not a scandal, not a scam, just a small, leveraged, acquisitive company running out of runway on patience from both its auditors and its exchange at the same time. Watch what actually happens by July 6. Either the stock finds a bid, the company reverse-splits to stay listed, or it doesn't — and each outcome tells you something different about how seriously to take the FY2026 guidance.
This article is for informational purposes only and does not constitute investment advice.
Todd Colpron is the Managing Partner of Eliakim Capital, a private investment and strategic advisory firm that manages its own capital while working alongside select family offices and private investors to identify and support exceptional opportunities.
Important Disclosure and Disclaimer
This publication is provided solely for general educational and informational purposes. Nothing contained in this publication constitutes, or should be construed as, investment, financial, legal, accounting, or tax advice; a recommendation or endorsement of any security, issuer, transaction, or investment strategy; or personalized advice based on any reader's particular financial circumstances.
This publication does not constitute an offer to sell, a solicitation of an offer to buy, or an invitation to enter into any transaction involving securities. Any offer or sale of securities may be made only through applicable offering documents and in accordance with applicable federal and state securities laws.
The Daily MicroCap and Eliakim Capital are not registered broker-dealers and do not execute securities transactions, accept investor funds, or provide brokerage services. Unless separately and expressly disclosed, neither The Daily MicroCap nor Eliakim Capital is acting as an investment adviser to any reader, and no advisory, fiduciary, attorney-client, or other professional relationship is created by this publication.
Information contained herein may be obtained from issuers, public filings, press releases, third-party sources, or other materials believed to be reliable; however, its accuracy, completeness, timeliness, and reliability are not guaranteed, and the information may not have been independently verified. Opinions and estimates are made as of the publication date and may change without notice.
Any statements regarding anticipated events, business prospects, financial performance, valuation, market opportunities, or future results are forward-looking and inherently uncertain. Actual outcomes may differ materially due to known and unknown risks.
Microcap and emerging-company securities can be highly speculative, volatile, illiquid, and subject to substantial dilution, limited publicly available information, and the risk of a complete loss of invested capital. Readers must conduct their own independent investigation and consult appropriately licensed financial, legal, and tax professionals before making any investment decision.
Neither The Daily MicroCap nor Eliakim Capital received compensation from the issuer for preparing or distributing this article.
Past performance is not indicative of future results. No representation or warranty is made regarding any investment outcome.